Thales S.A. vs Takeda Pharmaceutical Company Limited
Market cap comparison over time
Thales S.A.
$52.8B
Rank #253
Takeda Pharmaceutical Company Limited
$53.6B
Rank #250
Market Cap Over Time
Year-by-Year Comparison
| Year | Thales S.A. | Takeda Pharmaceutical Company Limited | Leader |
|---|---|---|---|
| 2026 | $52.8B | $53.6B | Takeda Pharmaceutical Company Limited |
| 2025 | $50.1B | $50.3B | Takeda Pharmaceutical Company Limited |
| 2024 | $29.7B | $41.6B | Takeda Pharmaceutical Company Limited |
| 2023 | $28.1B | $38.6B | Takeda Pharmaceutical Company Limited |
| 2022 | $24.5B | $37.6B | Takeda Pharmaceutical Company Limited |
| 2021 | $15.0B | $27.3B | Takeda Pharmaceutical Company Limited |
| 2020 | $14.7B | $31.2B | Takeda Pharmaceutical Company Limited |
| 2019 | $18.0B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $19.4B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $16.8B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $17.0B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $12.5B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $8.0B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $8.1B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $4.4B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $4.0B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $4.2B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $5.6B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $4.5B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $6.0B | $32.5B | Takeda Pharmaceutical Company Limited |
| 2006 | $5.5B | $39.6B | Takeda Pharmaceutical Company Limited |
| 2005 | $5.4B | $30.4B | Takeda Pharmaceutical Company Limited |
| 2004 | $4.9B | $24.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $3.5B | $19.6B | Takeda Pharmaceutical Company Limited |
| 2002 | $3.2B | $22.5B | Takeda Pharmaceutical Company Limited |
| 2001 | $4.9B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $6.4B | $30.0B | Takeda Pharmaceutical Company Limited |